Table 4.
Impact of RVP testing on antibiotic use at WFBH
| Outcome | Negative RVP (n = 100) | Positive RVPa (n = 50) | P Value |
|---|---|---|---|
| Antibiotic discontinued by 24 h, n (%) | 2 (2) | 5 (10) | .04 |
| Antibiotic de-escalated by 24 h, n (%) | 8 (8) | 13 (26) | <.01 |
| Antibiotic DOT, median (range), d | 9 (1–35) | 6 (1–53) | .03 |
| Antibiotic duration, median (range), d | 4.1 (0.5–14.9) | 3.5 (0.2–24) | .09 |
| Length of hospitalization, median (range), d | 4.3 (0.4–39.9) | 3.6 (0.9–26.0) | .25 |
| In-hospital mortality, n (%) | 3 (3) | 2 (4) | .75 |
Abbreviation: DOT, days of antibiotic therapy.
a
Viruses detected by RVP include influenza (38%), respiratory syncytial virus (20%), metapneumovirus (20%), rhino/enterovirus (18%), and coronavirus (4%).